標題: Titlebook: Diagnosis and Management of Hepatic Encephalopathy; A Case-based Guide Jasmohan S. Bajaj Book 2018 Springer International Publishing AG, pa [打印本頁] 作者: Harding 時間: 2025-3-21 18:19
書目名稱Diagnosis and Management of Hepatic Encephalopathy影響因子(影響力)
書目名稱Diagnosis and Management of Hepatic Encephalopathy影響因子(影響力)學科排名
書目名稱Diagnosis and Management of Hepatic Encephalopathy網(wǎng)絡(luò)公開度
書目名稱Diagnosis and Management of Hepatic Encephalopathy網(wǎng)絡(luò)公開度學科排名
書目名稱Diagnosis and Management of Hepatic Encephalopathy被引頻次
書目名稱Diagnosis and Management of Hepatic Encephalopathy被引頻次學科排名
書目名稱Diagnosis and Management of Hepatic Encephalopathy年度引用
書目名稱Diagnosis and Management of Hepatic Encephalopathy年度引用學科排名
書目名稱Diagnosis and Management of Hepatic Encephalopathy讀者反饋
書目名稱Diagnosis and Management of Hepatic Encephalopathy讀者反饋學科排名
作者: ingestion 時間: 2025-3-21 23:19
Fritz Otto,Melchior Palyi,G. S.t decrease portosystemic shunting by embolization of large spontaneous shunts or balloon-occluded retrograde transvenous obliteration of large spontaneous splenorenal shunts are also effective in prevention of recurrence of hepatic encephalopathy.作者: Little 時間: 2025-3-22 01:01
https://doi.org/10.1007/978-3-642-51322-0 killers, anxiolytics, neuroleptics, benzodiazepines, and antidepressants, may precipitate HE, necessitating dose reduction or avoidance; (iii) the cognitive impairment that defines HE complicates ACP and is a major reason supporting early ACP discussions; and (iv) HE increases caregiver burnout. Th作者: 譏諷 時間: 2025-3-22 05:48
Latest Concepts in Inpatient Hepatic Encephalopathy Management,ssible causes. Precipitating factors of HE must be treated if they are identified. Early detection of extrahepatic organ failure is vital for risk stratification purposes and to determine the need for organ support. Specific HE treatment should be initiated with a nonabsorbable disaccharide (i.e., l作者: 頭腦冷靜 時間: 2025-3-22 10:01 作者: 慷慨援助 時間: 2025-3-22 16:08 作者: 慷慨援助 時間: 2025-3-22 19:40
Diagnosis and Management of Hepatic EncephalopathyA Case-based Guide作者: needle 時間: 2025-3-23 00:02 作者: Institution 時間: 2025-3-23 02:17 作者: 殺子女者 時間: 2025-3-23 06:10 作者: 匍匐 時間: 2025-3-23 12:20 作者: Vulnerary 時間: 2025-3-23 17:56 作者: Hallmark 時間: 2025-3-23 19:05
Treatment Options for Covert Hepatic Encephalopathy, rifaximin, ammonia scavengers, branched-chain amino acids, and probiotics. In this chapter we review the existing evidence on these agents and explain treatment decisions using a case-based approach.作者: 混雜人 時間: 2025-3-24 00:37 作者: Obvious 時間: 2025-3-24 02:42 作者: d-limonene 時間: 2025-3-24 10:16
Fritz Otto,Melchior Palyi,G. S.pisodes of overt HE can prompt neuronal cell injury/death leading to irreversibility. This chapter describes a patient who embarks on the continuum of HE, describing precipitating factors involved in the pathogenesis of cognitive decline.作者: 血友病 時間: 2025-3-24 11:41
,Hepatic Encephalopathy: Pathophysiology—Brain,pisodes of overt HE can prompt neuronal cell injury/death leading to irreversibility. This chapter describes a patient who embarks on the continuum of HE, describing precipitating factors involved in the pathogenesis of cognitive decline.作者: Perennial長期的 時間: 2025-3-24 15:47
https://doi.org/10.1007/978-3-642-51322-0 understand each aspect in order to determine the etiology of the episode and to plan for prevention of recurrence. A strong initial workup based on the nomenclature will ensure a more successful outcome for the patient in the long run.作者: 特征 時間: 2025-3-24 22:14 作者: laxative 時間: 2025-3-25 00:36 作者: 同位素 時間: 2025-3-25 06:39 作者: OGLE 時間: 2025-3-25 08:32 作者: Heretical 時間: 2025-3-25 13:50
Definition and Changes in Nomenclature of Hepatic Encephalopathy,or psychiatric abnormalities ranging from subclinical alterations to coma. It is related to brain dysfunction from a combination of ammonia, endotoxins, and other neurotoxins with the end result being neuro-inflammation. Given the vast spectrum of manifestations, the nomenclature is detailed with mu作者: lavish 時間: 2025-3-25 16:45 作者: fidelity 時間: 2025-3-25 23:26 作者: 頭盔 時間: 2025-3-26 00:15 作者: 棲息地 時間: 2025-3-26 05:23
Treatment Options for Covert Hepatic Encephalopathy,er burden. However, due to a paucity of symptoms, covert hepatic encephalopathy (CHE) is often ignored or neglected by physicians as well as patients. The lack of consensus among experts for both diagnosis as well as treatment of CHE adds to this problem. Treatment options for CHE include lactulose,作者: 火花 時間: 2025-3-26 11:03
Latest Concepts in Inpatient Hepatic Encephalopathy Management,Current nomenclature recognizes type A HE (acute liver failure), type B (portosystemic shunts absent liver disease), and type C (liver disease). Recently, it has been observed that HE is an additional risk factor for death in patients with acute-on-chronic liver failure (ACLF). Thus, it has been pro作者: Collision 時間: 2025-3-26 13:08 作者: 畫布 時間: 2025-3-26 20:03
Hepatic Encephalopathy Diagnosis Conundrums,al centres with a research interest in hepatic encephalopathy (HE) to diagnose or exclude this disease, especially within the context of neurological comorbidity. Conclusions are drawn on definitions and practical strategies, which will hopefully be relevant also to non-specialist hepatology and gas作者: cardiovascular 時間: 2025-3-27 00:13 作者: 財主 時間: 2025-3-27 01:39
https://doi.org/10.1007/978-3-642-51322-0al centres with a research interest in hepatic encephalopathy (HE) to diagnose or exclude this disease, especially within the context of neurological comorbidity. Conclusions are drawn on definitions and practical strategies, which will hopefully be relevant also to non-specialist hepatology and gastroenterology practitioners.作者: Mammal 時間: 2025-3-27 07:55
https://doi.org/10.1007/978-3-642-51322-0or psychiatric abnormalities ranging from subclinical alterations to coma. It is related to brain dysfunction from a combination of ammonia, endotoxins, and other neurotoxins with the end result being neuro-inflammation. Given the vast spectrum of manifestations, the nomenclature is detailed with mu作者: BOOST 時間: 2025-3-27 10:10
Fritz Otto,Melchior Palyi,G. S.of the liver to clear gut-derived ammonia leads to an increase in blood ammonia and neurotoxicity. Portal-systemic shunting as well as a reduction in muscle quality and/or muscle mass loss further increase the risk of developing hyperammonemia. Systemic oxidative stress and inflammation together wit作者: Guaff豪情痛飲 時間: 2025-3-27 14:53
https://doi.org/10.1007/978-3-642-51322-0including nitrogenous waste and thus the factory for processing and detoxifying these compounds. In cirrhosis, this detoxification capacity is overwhelmed by a combination of impaired urea synthesis and bypassing of blood rich in ammonia directly into the systemic circulation as a result of portal h作者: PAGAN 時間: 2025-3-27 21:07
Fritz Otto,Melchior Palyi,G. S.psychometric or neurophysiological tests is necessary for identifying minimal HE and such tests are also very useful for description of grad 1 HE. We put emphasis on how to apply and interpret the tests in clinical practise, i.e. in patients with differing cognitive prerequisites and co-morbid disea作者: 一窩小鳥 時間: 2025-3-27 23:16
Fritz Otto,Melchior Palyi,G. S.er burden. However, due to a paucity of symptoms, covert hepatic encephalopathy (CHE) is often ignored or neglected by physicians as well as patients. The lack of consensus among experts for both diagnosis as well as treatment of CHE adds to this problem. Treatment options for CHE include lactulose,作者: Neuralgia 時間: 2025-3-28 05:12
https://doi.org/10.1007/978-3-642-51322-0Current nomenclature recognizes type A HE (acute liver failure), type B (portosystemic shunts absent liver disease), and type C (liver disease). Recently, it has been observed that HE is an additional risk factor for death in patients with acute-on-chronic liver failure (ACLF). Thus, it has been pro作者: MOAT 時間: 2025-3-28 09:58
Fritz Otto,Melchior Palyi,G. S. portosystemic shunt (TIPS). Minimal hepatic encephalopathy (MHE) affects 20–60% of patients with liver cirrhosis. Recurrence of HE is seen in 47–57% of patients at the end of 1 year. Recurrence of HE is associated with poor prognosis, increased hospitalization, healthcare burden, morbidity, and mor作者: 無法取消 時間: 2025-3-28 14:09
https://doi.org/10.1007/978-3-642-51322-0al centres with a research interest in hepatic encephalopathy (HE) to diagnose or exclude this disease, especially within the context of neurological comorbidity. Conclusions are drawn on definitions and practical strategies, which will hopefully be relevant also to non-specialist hepatology and gas作者: 苦惱 時間: 2025-3-28 15:26
https://doi.org/10.1007/978-3-642-51322-0 With a focus on symptom control and advance care planning (ACP) discussions, the integration of care using palliative care principles enhances health-related quality of life, decreases healthcare utilization, and improves patient and family satisfaction. The routine use of palliative principles has作者: 受辱 時間: 2025-3-28 20:54 作者: 捕鯨魚叉 時間: 2025-3-28 23:25
Jasmohan S. BajajStructured in a case-based approach for ease of use.Highlights exploratory new therapies and treatment targets.Written by experts in the field
